We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Lamellar Transplant With Lyophilized Corneas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00409955
Recruitment Status : Completed
First Posted : December 12, 2006
Last Update Posted : December 12, 2006
University of Sao Paulo
Sorocaba Eye Bank
Information provided by:
Federal University of São Paulo

December 11, 2006
December 12, 2006
December 12, 2006
December 2005
Not Provided
  • Topography
  • Orbscan
  • Pachmetry
  • Ultrasound Biomicroscopy
  • Confocal Microscopy
  • Masked Examiner to evaluate transparency and quality of the transplant
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
Lamellar Transplant With Lyophilized Corneas
Randomized Clinical Trial for Lamellar Transplants Using Lyophilized and Optisol Corneas
- The goals of this study are to develop a lyophilization method for anterior lamellar transplants in Brasil and to make a comparative analysis among patients transplanted with lyophilized and optisol corneas
  • After the development of a techinique to lyophilize corneas, we randomly assingned 20 patients with keratoconus and visual acuity of < 20/60, who signed the consent term and divided them into 2 groups. One group was transplanted with lyophilized corneas and the other group with optisol corneas.
  • Patients are being followed for 6 months with visual acuity, refraction, topography, orbscan, pachmetry, ultrasound biomicroscopy and confocal microscopy.
  • Results are going to be statistically analysed by SPSS program.
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Procedure: Lamellar transplant with lyophilized corneas
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
December 2006
Not Provided

Inclusion Criteria:

  • Keratoconus patient
  • BCVA < 20/60
  • No systemic diseases
  • Who signed the inform consent

Exclusion Criteria:

  • BCVA > 20/60
  • Presence of deep opacities
  • Systemic diseases
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
CEP 1536/05
Not Provided
Not Provided
Not Provided
Not Provided
Federal University of São Paulo
  • University of Sao Paulo
  • Sorocaba Eye Bank
Principal Investigator: Roberta JM Farias, MD Federal University of Sao Paulo
Federal University of São Paulo
December 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP